Stay updated on Dose Dense Paclitaxel with Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Dose Dense Paclitaxel with Pembrolizumab Clinical Trial page.

Latest updates to the Dose Dense Paclitaxel with Pembrolizumab Clinical Trial page
- Check5 days agoChange DetectedThe related topic entries for 'Ovarian cancer' and 'MedlinePlus Genetics' have been removed.SummaryDifference0.2%

- Check12 days agoChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.1%

- Check19 days agoChange DetectedAdded a related topics section for ovarian cancer with a link to MedlinePlus Genetics.SummaryDifference0.2%

- Check26 days agoChange DetectedRevision: v3.4.3 was added; the Ovarian cancer-related topics were removed from the related topics. The core study details remain unchanged.SummaryDifference0.2%

- Check55 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and related operating-status guidance (Revision: v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedThe page now displays a site-wide notice about funding and operation status and lists the revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Dose Dense Paclitaxel with Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose Dense Paclitaxel with Pembrolizumab Clinical Trial page.